ANDREW NORRIS: Open Payments
NPI 1780031971 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$153 in 8 payments from 6 companies in 2025. Trend: 2023 $252 · 2024 $481 · 2025 $153
Food & beverage: $153
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 2 | $41 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| Ardelyx, Inc. | 1 | $23 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $22 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| Apellis Pharmaceuticals, Inc. | 1 | $14 |
Products named: Fabhalta, FARXIGA, IBSRELA, JARDIANCE, Kerendia, Empaveli.
Industry payments across NC — which companies pay providers there.
